Kawahara Eiji, Fujii Mikio, Ida Yoshiteru, Akita Hiroyuki
School of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan.
Chem Pharm Bull (Tokyo). 2006 Mar;54(3):387-90. doi: 10.1248/cpb.54.387.
Direct beta-glucosidation between (-)-myrtenol and nerol and D-glucose (3) using the immobilized beta-glucosidase from almonds with the synthetic prepolymer ENTP-4000 gave myrtenyl O-beta-D-glucoside (4) and neryl O-beta-D-glucoside (10), respectively. The coupling of the myrtenyl or neryl O-beta-D-glucopyranoside congeners (7 or 13) and 2,3,4-tri-O-benzoyl-beta-L-arabinopyranosyl bromide (8) afforded the coupled products (9 or 14), respectively. Deprotection of the coupled products (9 or 14) afforded the synthetic myrtenyl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside (Sacranoside A, 1) or neryl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside (Sacranoside B, 2), respectively.
使用杏仁固定化β-葡萄糖苷酶与合成预聚物ENTP-4000,使(-)-桃金娘烯醇与橙花醇和D-葡萄糖(3)直接进行β-葡萄糖苷化反应,分别得到桃金娘烯基O-β-D-葡萄糖苷(4)和橙花烯基O-β-D-葡萄糖苷(10)。桃金娘烯基或橙花烯基O-β-D-吡喃葡萄糖苷类似物(7或13)与2,3,4-三-O-苯甲酰基-β-L-阿拉伯吡喃糖基溴(8)偶联,分别得到偶联产物(9或14)。偶联产物(9或14)脱保护后,分别得到合成的桃金娘烯基6-O-α-L-阿拉伯吡喃糖基-β-D-吡喃葡萄糖苷(Sacranoside A,1)或橙花烯基6-O-α-L-阿拉伯吡喃糖基-β-D-吡喃葡萄糖苷(Sacranoside B,2)。